These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4205299)

  • 41. Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09).
    Kirkpatrick BD; Bentley MD; Thern AM; Larsson CJ; Ventrone C; Sreenivasan MV; Bourgeois L
    Clin Diagn Lab Immunol; 2005 Sep; 12(9):1127-9. PubMed ID: 16148184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of live typhoid vaccine in chimpanzees.
    Cvjetanović B; Mel DM; Felsenfeld O
    Bull World Health Organ; 1970; 42(4):499-507. PubMed ID: 4194259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation of typhoid somatic-antigen vaccine. III. The rabbit intracutaneous challenge with Salmonella typhi in mucin.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():35-41. PubMed ID: 13886263
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of the efficacy of oral typhoid vaccine in animal and man].
    Saletti M; Panero C; Genna G; Silli U
    Ann Sclavo; 1972; 14(5):611-9. PubMed ID: 4669415
    [No Abstract]   [Full Text] [Related]  

  • 45. Intradermal typhoid vaccination by jet injection.
    Dimache G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):157-63. PubMed ID: 3426873
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparative study of the effectiveness of corpuscular and chemical paratyphoid B vaccines in monkey experiments using subcutaneous and parenteral administration.
    Stepanova LK; Gekker VD; Stasilevish ZK; Sergeyeva NS
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):386-97. PubMed ID: 4629402
    [No Abstract]   [Full Text] [Related]  

  • 47. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effectiveness of the vaccine of Vi-antigen of Salmonella typhosa in children and adolescents].
    D'iachenko PN; Dzhumaliev ND; Koshotov T; Zhoroev Zh
    Zdravookhr Kirg; 1975; (5):49-53. PubMed ID: 1943
    [No Abstract]   [Full Text] [Related]  

  • 50. Active immunization against Salmonella typhi by oral administration of fast neutron irradiated cells.
    Dima FV; Ivanov D; Dima SV
    Ann N Y Acad Sci; 1994 Aug; 730():348-9. PubMed ID: 8080207
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
    Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 53. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cross-reacting antigens of Opisthorchis felineus and Salmonella typhi and their possible effect on the clinical course of typhoid fever].
    Lepekhin AV; Ratner GM; Meniavtseva TA
    Med Parazitol (Mosk); 1990; (4):33-6. PubMed ID: 2233535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Salmonella typhi by PCR among recipients of oral typhoid vaccine lots.
    Arya SC
    J Clin Microbiol; 1994 Apr; 32(4):1133. PubMed ID: 8027333
    [No Abstract]   [Full Text] [Related]  

  • 56. Controlled field trials of three different oral killed typhoid vaccines in India.
    Chuttani CS
    Dev Biol Stand; 1976; 33():98-101. PubMed ID: 782977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The importance of Vi- and O-antigens for formation of immunity to typhoid infections].
    Kolobova LF; Pershin BB
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):97-101. PubMed ID: 5511394
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of a live oral typhoid vaccine in human volunteers.
    Hornick RB; DuPont HL; Levine MM; Gilman RH; Woodward WE; Snyder MJ; Woodward TE
    Dev Biol Stand; 1976; 33():89-92. PubMed ID: 782976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why are typhoid vaccines not recommended for epidemic typhoid fever?
    Taylor DN; Levine MM; Kuppens L; Ivanoff B
    J Infect Dis; 1999 Dec; 180(6):2089-90. PubMed ID: 10558978
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.